帕金森病中的REM密度:与运动,认知,自主功能和多巴胺作用药物药物相关
Andrew Dagay1,2, Shlomit Katzav2,3,4, Noa Elisha4
1Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
NPJ Parkinson's disease
|July 14, 2025
概括
患有较低REM密度的帕金森病患者表现出较差的步态和运动能力,特别是在复杂的任务中. 晚上服用药物可以通过解决运动缺陷来改善REM密度.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 运动障碍 运动障碍
背景情况:
- 在帕金森病 (PD) 中,REM密度降低,与勃拉迪基尼西亚相关.
- 这表明REM睡眠和PD中的运动功能之间存在潜在的联系.
研究的目的:
- 调查REM密度和步态,认知功能和心率变化 (HRV) 在PD患者之间的关系.
- 探索多巴胺激素药物时间对REM密度的影响.
主要方法:
- 77名PD患者接受了夜间的多睡眠图,以测量REM密度.
- 在行走和双重任务条件下使用可穿戴传感器评估了步行和移动性.
- 还分析了心率变化 (HRV).
主要成果:
- 较低的REM密度与步行和移动能力受损相关,特别是在双重任务和转时.
- 在REM密度和HRV之间没有发现显著的关联.
- 晚上缓释多巴胺激素药物治疗的患者的REM密度高于未服用药物或白天服用药物的患者.
结论:
- 在PD中REM密度与运动和认知功能有关,特别是步态控制.
- 晚上服用多巴胺作用药物可能会增加REM密度,可能是通过改善运动缺陷.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.0K
10:32Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
55.5K
相关概念视频
Parkinson's Disease: Treatment
385
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
385
Parkinson's Disease: Overview
715
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
715
Neural Regulation
40.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.2K
